Furthermore, this study may provide the preclinical evidence for the combined use of GRb1 and Emodin on ischemic stroke, indicating that GRb1+Emodin can be a potential candidate for further clinical trials. The gene discussed is PIK3R1; the disease is ischemic stroke.